CANCER 2026 Amar Balihodzic
Medical University of Graz, STYRIA, Austria
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
BCL-XL and MCL-1 determine cell fate after activation of the tumour suppressor TP53/TRP53 (131028)
4:00 PM
Shuai Huang
Session 8: Molecular regulators of oncogenesis and novel approaches
Dual inhibition of KIF11 and BCL-XL or MCL-1 rewires mitotic cell fates and efficiently kills lung cancer cells (#111)
5:40 PM
Amar Balihodzic
Welcome Reception & Poster Session 1